DE68904330T2 - Hirudin-varianten, deren verwendung und verfahren zu deren herstellung. - Google Patents

Hirudin-varianten, deren verwendung und verfahren zu deren herstellung.

Info

Publication number
DE68904330T2
DE68904330T2 DE8989400621T DE68904330T DE68904330T2 DE 68904330 T2 DE68904330 T2 DE 68904330T2 DE 8989400621 T DE8989400621 T DE 8989400621T DE 68904330 T DE68904330 T DE 68904330T DE 68904330 T2 DE68904330 T2 DE 68904330T2
Authority
DE
Germany
Prior art keywords
production
hirudin variants
hirudin
variants
improving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8989400621T
Other languages
English (en)
Other versions
DE68904330D1 (de
Inventor
Michael Courtney
Eric Degryse
Gerard Loison
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Transgene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene SA filed Critical Transgene SA
Publication of DE68904330D1 publication Critical patent/DE68904330D1/de
Application granted granted Critical
Publication of DE68904330T2 publication Critical patent/DE68904330T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/815Protease inhibitors from leeches, e.g. hirudin, eglin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855Proteins from animals other than mammals or birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Removal Of Specific Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
DE8989400621T 1988-03-08 1989-03-06 Hirudin-varianten, deren verwendung und verfahren zu deren herstellung. Expired - Lifetime DE68904330T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8802925A FR2628429B1 (fr) 1988-03-08 1988-03-08 Variants de l'hirudine, leurs utilisations et les procedes pour les obtenir

Publications (2)

Publication Number Publication Date
DE68904330D1 DE68904330D1 (de) 1993-02-25
DE68904330T2 true DE68904330T2 (de) 1993-05-19

Family

ID=9364012

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989400621T Expired - Lifetime DE68904330T2 (de) 1988-03-08 1989-03-06 Hirudin-varianten, deren verwendung und verfahren zu deren herstellung.

Country Status (10)

Country Link
US (1) US5087613A (de)
EP (1) EP0332523B1 (de)
JP (1) JP2961118B2 (de)
AT (1) ATE84571T1 (de)
CA (1) CA1341429C (de)
DE (1) DE68904330T2 (de)
ES (1) ES2036809T3 (de)
FR (1) FR2628429B1 (de)
GR (1) GR3007254T3 (de)
PT (1) PT89923B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8907110D0 (en) * 1988-05-04 1989-05-10 Ciba Geigy Ag Improvements in the production of polypeptides
US5268296A (en) * 1988-06-11 1993-12-07 Ciba-Geigy Corporation DNA vector and recombinant host cell for production of hirullin P6 and P18
DE3835815A1 (de) * 1988-10-21 1990-04-26 Hoechst Ag Neue isohirudine
FR2646437B1 (fr) * 1989-04-28 1991-08-30 Transgene Sa Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
WO1991008229A1 (de) * 1989-12-01 1991-06-13 Basf Aktiengesellschaft Hirudinpolyalkylenglykolkonjugate
US5672585A (en) * 1990-04-06 1997-09-30 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5612311A (en) * 1990-04-06 1997-03-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5780303A (en) * 1990-04-06 1998-07-14 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US6521594B1 (en) 1990-04-06 2003-02-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5574012A (en) * 1990-07-24 1996-11-12 Merrell Pharmaceuticals Inc. Analogs of hirudin having anti-platelet activity
ZA915658B (en) * 1990-07-24 1992-05-27 Merrell Dow Pharma Analogs of hirudin having antiplatelet activity
EP0540574B1 (de) * 1990-07-24 1996-09-11 Merrell Pharmaceuticals Inc. Antigerinnungspeptide
GB9023149D0 (en) * 1990-10-24 1990-12-05 British Bio Technology Proteins and nucleic acids
US5837808A (en) * 1991-08-20 1998-11-17 Baxter International Inc. Analogs of hirudin
WO1993004082A1 (en) * 1991-08-20 1993-03-04 Baxter International Inc. Analogs of hirudin
GB9209032D0 (en) * 1992-04-25 1992-06-10 Ciba Geigy Ag New peptide derivatives
ATE246203T1 (de) * 1993-06-11 2003-08-15 Merrell Pharma Inc Trifunktionelle antithrombin-und antiplättchenpeptide
DE4404168A1 (de) * 1994-02-10 1995-08-17 Hoechst Ag Hirudinderivate und Verfahren zu deren Herstellung
US8377863B2 (en) 2007-05-29 2013-02-19 Unigene Laboratories Inc. Peptide pharmaceutical for oral delivery
ES2929218T3 (es) 2015-01-12 2022-11-28 Enteris Biopharma Inc Formas farmacéuticas orales sólidas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341417C (fr) * 1984-03-27 2003-01-21 Paul Tolstoshev Vecteurs d'expression de l'hirudine, cellules transformees et procede de preparation de l'hirudine
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens
FR2607517B2 (fr) * 1986-12-01 1989-12-22 Transgene Sa Vecteurs d'expression de variants de l'hirudine dans les levures, procede et produit obtenu

Also Published As

Publication number Publication date
EP0332523A1 (de) 1989-09-13
ES2036809T3 (es) 1993-06-01
CA1341429C (fr) 2003-05-27
ATE84571T1 (de) 1993-01-15
PT89923B (pt) 1994-05-31
EP0332523B1 (de) 1993-01-13
JPH029390A (ja) 1990-01-12
PT89923A (pt) 1989-11-10
DE68904330D1 (de) 1993-02-25
FR2628429B1 (fr) 1990-12-28
GR3007254T3 (de) 1993-07-30
US5087613A (en) 1992-02-11
JP2961118B2 (ja) 1999-10-12
FR2628429A1 (fr) 1989-09-15

Similar Documents

Publication Publication Date Title
DE68904330T2 (de) Hirudin-varianten, deren verwendung und verfahren zu deren herstellung.
ATA76286A (de) Glaskörperchen mit modifizierter benetzbarkeit, verfahren zu deren herstellung und verwendung derselben
DE59404480D1 (de) Fullerenderivate, verfahren zur herstellung und deren verwendung
ATE166049T1 (de) Phthalimidoperoxihexansäure, verfahren zu deren herstellung und deren verwendung
DE68907057T2 (de) Nährstoffzusammensetzung und verfahren zu deren herstellung.
DE3879613D1 (de) Schnellrueckstellbares ptfe und verfahren zu dessen herstellung.
DE3667779D1 (de) Glasspinnfaden und verfahren zu seiner herstellung.
DE3582576D1 (de) Dithioketo-pyrrolo-pyrrole, verfahren zu deren herstellung und verwendung.
DE3683196D1 (de) Zusammengesetzte mehrschichtige hohlfasern und verfahren zu deren herstellung.
DE3585198D1 (de) Struktur mit kontrolliertem molekuel und verfahren zu deren herstellung.
DE68905735T2 (de) Synthetisches geschmolzenes quarzglas und verfahren zu dessen herstellung.
DE3880869D1 (de) Verstaerkter glasgegenstand und verfahren zu dessen herstellung.
DE68923959T2 (de) Glykosid-derivate, polymere enthaltend glykosid-derivate, verfahren zur herstellung und deren verwendung.
DE3777189D1 (de) Modifizierte fasererzeugnisse und deren verfahren zur herstellung.
DE3681188D1 (de) Polyarylen-thioetherfasern von hoher qualitaet und verfahren zu deren herstellung.
DE68910523T2 (de) Trizyklische 3-oxo-propannitril-derivate und verfahren zu deren herstellung.
DE3865927D1 (de) Tetrahydroindazolyl-benzoxazine, verfahren zu deren herstellung und deren anwendung.
DE58901183D1 (de) Flexible fuehrungsschiene und verfahren zur deren herstellung.
DE3887445T2 (de) Verfahren zur herstellung von glukagonhomologen und deren verwendung.
DE3886936D1 (de) 2,5,6,7-TETRANOR-4,8-INTER-m-PHENYLEN 2-PGI-DERIVATE, VERFAHREN ZUR HERSTELLUNG UND DEREN VERWENDUNG.
DE3678003D1 (de) Anionisch modifizierte polysaccharide, verfahren zu deren herstellung und deren verwendung.
DE3782599D1 (de) Laser mit monolitisch integrierten, planaren elementen und verfahren zu deren herstellung.
DE3679739D1 (de) Dekorative fassung und verfahren zu deren herstellung.
DE3879904D1 (de) Klebmischung, verfahren zu deren herstellung und verwendung.
DE3868300D1 (de) Reaktivfarbstoffe, verfahren zu deren herstellung und deren verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SCHERING AG, 13353 BERLIN, DE

8327 Change in the person/name/address of the patent owner

Owner name: BAYER SCHERING PHARMA AG, 13353 BERLIN, DE

8327 Change in the person/name/address of the patent owner

Owner name: BAYER SCHERING PHARMA AKIENGESELLSCHAFT, 13353, DE